Chesworth, Richard,Munchhof, Michael John,Jin, Lei,Boriack-Sjodin, Paula Ann,Duncan, Kenneth W.
申请号：
AU2018202150
公开号：
AU2018202150B2
申请日:
2018.03.26
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2018202150B220190711.pdf#####ABSTRACT Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5 mediated disorders are also described.
